4.6 Article

Using Targeted Nano-Antibiotics to Improve Antibiotic Efficacy against Staphylococcus aureus Infections

期刊

ANTIBIOTICS-BASEL
卷 12, 期 6, 页码 -

出版社

MDPI
DOI: 10.3390/antibiotics12061066

关键词

nano-antibiotic; targeted delivery; S; aureus; nano-medicine; enhanced pharmacokinetic

向作者/读者索取更多资源

Developing novel antibiotic delivery strategies is essential to increase the bioavailability of antibiotics at infection sites. In this study, fluoroquinolone antibiotics ciprofloxacin and levofloxacin were encapsulated into polymer-based nano-carriers with anti-staphylococcal antibodies as ligand molecules. The targeted nano-antibiotic showed enhanced antimicrobial activity against S. aureus in both planktonic and biofilm forms compared to free-form antibiotic. The release profile of the targeted nano-antibiotic treatment was found to influence its efficacy.
The poor bioavailability of antibiotics at infection sites is one of the leading causes of treatment failure and increased bacterial resistance. Therefore, developing novel, non-conventional antibiotic delivery strategies to deal with bacterial pathogens is essential. Here, we investigated the encapsulation of two fluoroquinolones, ciprofloxacin and levofloxacin, into polymer-based nano-carriers (nano-antibiotics), with the goal of increasing their local bioavailability at bacterial infection sites. The formulations were optimized to achieve maximal drug loading. The surfaces of nano-antibiotics were modified with anti-staphylococcal antibodies as ligand molecules to target S. aureus pathogens. The interaction of nano-antibiotics with the bacterial cells was investigated via fluorescent confocal microscopy. Conventional tests (MIC and MBC) were used to examine the antibacterial properties of nano-antibiotic formulations. Simultaneously, a bioluminescence assay model was employed, revealing the rapid and efficient assessment of the antibacterial potency of colloidal systems. In comparison to the free-form antibiotic, the targeted nano-antibiotic exhibited enhanced antimicrobial activity against both the planktonic and biofilm forms of S. aureus. Furthermore, our data suggested that the efficacy of a targeted nano-antibiotic treatment can be influenced by its antibiotic release profile.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据